The Minor Ailments and Contraception Service (MACS) was launched on June 1, 2023. The Ministry extends its appreciation to pharmacists for the ongoing success of MACS and pharmacists prescribing. For more information, refer to Pharmacist scope of practice.
The following monitoring data demonstrates the uptake of MACS in the first year between June 1, 2023, and May 31, 2024. To view an infographic overview, visit Pharmacists Prescribing for Minor Ailments and Contraception (PPMAC) 1 year overview (PDF, 188KB).
*Submitted at least 1 PharmaCare claim in the previous year
Assessment | % of services |
---|---|
Contraception | 20 |
Urinary tract infection (uncomplicated) | 20 |
Conjunctivitis | 9 |
Allergic rhinitis | 7 |
Herpes labialis (cold sore) | 6 |
Dermatitis | 6 |
The Ministry of Health has developed a comprehensive evaluation plan and is working with partners to evaluate the impact of pharmacists assessing and prescribing through MACS.
Refer to PPMAC evaluation framework (PDF, 97KB) for an overview of the evaluation plan.
The goals of the MACS evaluation are to:
As part of the evaluation plan, pharmacists and members of the public may be invited to participate in surveys. All perspectives are valued and will help the Ministry improve the program.
Check this page for ongoing updates as new data becomes available.